Global Anti-Smoking Products Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Anti-Smoking Products Market Research Report 2024
The smoking cessation and nicotine de-addiction market is categorized into three major segments including drug therapy, Nicotine Replacement Therapy (NRT), and Electronic cigarettes (E-cigarettes).
According to Mr Accuracy reports’s new survey, global Anti-Smoking Products market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Anti-Smoking Products market research.
Key companies engaged in the Anti-Smoking Products industry include Pfizer, Cipla, Novartis International, GSK, Takeda pharmaceutical, McNeil AB, Revolymer plc, Imperial Tobacco and Elder Pharma, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Anti-Smoking Products were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Anti-Smoking Products market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Anti-Smoking Products market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Pfizer
Cipla
Novartis International
GSK
Takeda pharmaceutical
McNeil AB
Revolymer plc
Imperial Tobacco
Elder Pharma
NJOY
VMR products
Lorillard
VaporCorp
Segment by Type
Nicotine Replacement Therapy
Drug therapy
E-cigarettes
Smokers aged 18–24
Smokers aged 25–44
Smokers aged 45–64
Smokers aged 65 years or older
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Anti-Smoking Products report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to Mr Accuracy reports’s new survey, global Anti-Smoking Products market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Anti-Smoking Products market research.
Key companies engaged in the Anti-Smoking Products industry include Pfizer, Cipla, Novartis International, GSK, Takeda pharmaceutical, McNeil AB, Revolymer plc, Imperial Tobacco and Elder Pharma, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Anti-Smoking Products were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Anti-Smoking Products market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Anti-Smoking Products market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Pfizer
Cipla
Novartis International
GSK
Takeda pharmaceutical
McNeil AB
Revolymer plc
Imperial Tobacco
Elder Pharma
NJOY
VMR products
Lorillard
VaporCorp
Segment by Type
Nicotine Replacement Therapy
Drug therapy
E-cigarettes
Segment by Application
Smokers aged 18–24
Smokers aged 25–44
Smokers aged 45–64
Smokers aged 65 years or older
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Anti-Smoking Products report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source